Indication
Soft Tissue Sarcoma of the Trunk and Extremities
1 clinical trial
2 products
Clinical trial
A Phase I Study of Nivolumab and Intratumoral BO 112 for Resectable Soft Tissue SarcomaStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Product
Nanoplexed Poly I:C BO-112Product
Nivolumab